摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-nitrochalcone | 7473-93-0

中文名称
——
中文别名
——
英文名称
2-nitrochalcone
英文别名
3-(2-nitrophenyl)-1-phenylprop-2-en-1-one
2-nitrochalcone化学式
CAS
7473-93-0
化学式
C15H11NO3
mdl
MFCD00031069
分子量
253.257
InChiKey
KTXHLWZQKQDFRF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    124-128°C
  • 稳定性/保质期:
    如果遵照规格使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    62.9
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xi
  • 储存条件:
    密封在阴凉干燥的环境中。

SDS

SDS:25393200c210a60414533585f78b2a37
查看
Name: 2-Nitrochalcone Material Safety Data Sheet
Synonym: None Known
CAS: 7473-93-0
Section 1 - Chemical Product MSDS Name:2-Nitrochalcone Material Safety Data Sheet
Synonym:None Known

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
7473-93-0 2-Nitrochalcone ca. 100 unlisted
Hazard Symbols: XI
Risk Phrases: 38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to skin.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
Causes skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam. Use agent most appropriate to extinguish fire.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 7473-93-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystals
Color: pale yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 124-125 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C15H11NO3
Molecular Weight: 253.0819

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Will not occur.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 7473-93-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-Nitrochalcone - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 38 Irritating to skin.
Safety Phrases:
S 37 Wear suitable gloves.
WGK (Water Danger/Protection)
CAS# 7473-93-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 7473-93-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7473-93-0 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途

2-硝基查耳酮是一种有用的研宄化学品,广泛应用于有机合成和其他化学过程。

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-nitrochalconetin氯化铵 作用下, 以 乙醇 为溶剂, 反应 72.0h, 以87%的产率得到2-苯基喹啉
    参考文献:
    名称:
    由3-(2-硝基苯基)-3-羟基丙烷化学选择性合成喹啉N-氧化物
    摘要:
    3-(2-硝基苯基)-3-羟基丙烷与Zn / NH 4 Cl的反应以80-90%的产率得到了相应的喹啉N-氧化物。反应引发硝基的还原,得到相应的羟胺,将其分子内缩合,然后脱水得到喹啉N-氧化物。尽管在EtOH / H 2 O中用Zn / NH 4 Cl处理2-硝基查尔酮会降低产率生成喹啉N-氧化物,但是在回流EtOH / H 2 O中2-硝基查尔酮与Sn / NH 4 Cl的反应以80%的收率得到了喹啉N-氧化物。J.杂环化​​学。(2010)。
    DOI:
    10.1002/jhet.485
  • 作为产物:
    描述:
    2-Nitrochalkondibromid 在 sodium iodide 作用下, 以 二甲基亚砜异丙醇 为溶剂, 生成 2-nitrochalcone
    参考文献:
    名称:
    Raghavan, R. S.; Velayutham, K.; Rajendran, V., Indian Journal of Chemistry, Section A: Inorganic, Physical, Theoretical and Analytical, 1984, vol. 23, # 6, p. 466 - 469
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Application of Silicon-Initiated Water Splitting for the Reduction of Organic Substrates
    作者:Ashot Gevorgyan、Satenik Mkrtchyan、Tatevik Grigoryan、Viktor O. Iaroshenko
    DOI:10.1002/cplu.201800131
    日期:2018.5
    several important classes of organic compounds is described. It is found that the reductive water splitting can be promoted by several metalloids among which silicon shows the best efficiency. The developed methodologies were applied for the reduction of nitro compounds, N-oxides, sulfoxides, alkenes, alkynes, hydrodehalogenation as well as for the gram-scale synthesis of several substrates of industrial
    描述了使用水作为氢的供体,其适合于还原几种重要类别的有机化合物。发现还原水分解可以通过几种准金属来促进,其中硅显示出最佳的效率。所开发的方法学被用于还原硝基化合物,N-氧化物,亚砜,烯烃,炔烃,加氢脱卤作用以及几种工业上具有重要意义的底物的克级合成。
  • Diversified Transformations of Tetrahydroindolizines to Construct Chiral 3-Arylindolizines and Dicarbofunctionalized 1,5-Diketones
    作者:Dong Zhang、Zhishan Su、Qianwen He、Zhikun Wu、Yuqiao Zhou、Chenjing Pan、Xiaohua Liu、Xiaoming Feng
    DOI:10.1021/jacs.0c07066
    日期:2020.9.16
    four-stereogenic centered tetrahydroindolizine intermediates could be efficiently transferred into axially chirality in 3-arylindolizines and vicinal pyridyl and aryl substituted 1,5-diketones. In addition, densely functionalized cyclopropanes and bridged cyclic compound were also discovered depended on the nature of the pyridinium ylides. Mechanism studies were involved to explain the stereochemistry during the
    以有效方式对具有结构和功能相似性或差异的小分子集合进行对映选择性多样化合成是有吸引力的,但也是一项艰巨的挑战。四氢吲哚嗪的不对称制备和支化转化为构建具有官能团和立体化学多样性的含 N-杂环的支架提供了一种有用的方法。在此,我们报告了通过吡啶鎓叶立德和烯酮之间的初始非对映选择性和对映选择性 [3+2] 环加成,在多样化的顺序转化之后实现的突破。手性 N,N'-二氧化物-土金属配合物能够原位生成具有旋光活性的四氢茚茚,通过强烈的背景反应形成外消旋体。结合有意的顺序转化,包括方便的重基氧化和光活性 aza-Norrish II 重排,四氢茚茚中间体被转化为最终文库,包括 3-芳基茚衍生物和双碳功能化的 1,5-二羰基化合物。更重要的是,四立体中心四氢茚茚中间体的立体化学可以有效地转化为 3-芳基茚和邻位吡啶基和芳基取代的 1,5-二酮的轴向手性。此外,根据吡啶鎓叶立德的性质,还发现了稠密官能化的
  • Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibition
    作者:Gaurav Joshi、Manisha Sharma、Sourav Kalra、Navnath S. Gavande、Sandeep Singh、Raj Kumar
    DOI:10.1016/j.bioorg.2020.104620
    日期:2021.2
    (2a-2x) as xanthine oxidase inhibitors (XOIs). A docking model was developed for the prediction of XO inhibitory activity of our novel compounds. Furthermore, our compounds anticancer activity results in low XO expression and XO-harboring cancer cells both in 2D and 3D-culture models are presented and discussed. Among the array of synthesized compounds, 2b and 2m emerged as potent XO inhibitors having
    黄嘌呤氧化酶 (XO) 主要用于开发抗高尿酸血症/抗痛风剂,因为它催化黄嘌呤和次黄嘌呤转化为尿酸。由于催化过程中活性氧 (ROS) 的产生和致癌物质的代谢活化,XO 在各种癌症中的过度表达非常相关。在此,我们报告了一系列 3,5-二芳基-4,5-二氢-1 H-吡唑甲醛衍生物 ( 2a - 2x) 作为黄嘌呤氧化酶抑制剂 (XOI)。开发了一种对接模型,用于预测我们的新型化合物的 XO 抑制活性。此外,我们的化合物抗癌活性导致 2D 和 3D 培养模型中的低 XO 表达和 XO 携带癌细胞。合成的化合物的阵列中,图2b和2米成为具有IC强效抑制剂XO 50值分别为 9.32 ± 0.45 µM 和 10.03 ± 0.43 µM。这两种化合物均诱导细胞凋亡,在 G1 期停止细胞周期进程,提高 ROS 水平,改变线粒体膜电位,并抑制抗氧化酶。由于我们的化合物诱导的氧化应激增加,细胞中 miRNA
  • Asymmetric epoxidation of substituted chalcones and chalcone analogues catalyzed by α-d-glucose- and α-d-mannose-based crown ethers
    作者:Attila Makó、Zsolt Rapi、György Keglevich、Áron Szöllősy、László Drahos、László Hegedűs、Péter Bakó
    DOI:10.1016/j.tetasy.2010.05.009
    日期:2010.4
    The chiral monoaza-15-crown-5 lariat ethers annellated to methyl-4,6-O-benzylidene-α-d-glucopyranoside-1 or mannopyranoside 2 have been applied as phase-transfer catalysts in the epoxidation of substituted chalcones and chalcone analogues with tert-butylhydroperoxide resulting in significant asymmetric induction. It was found that the position of the substituents in the aromatic ring of the chalcone
    与甲基-4,6- O-亚苄基-α-d-吡喃吡喃糖苷-1或甘露吡喃糖苷2甲基化的手性单氮杂-15冠-5套索状醚已被用作相取代的催化剂,用于取代的查耳酮和查尔酮类似物的环氧化与叔-butylhydroperoxide导致显著不对称诱导。发现查尔酮的芳环中取代基的位置对化学收率和对映体过量都有影响。在邻位取代的模型化合物中,对映选择性最低(62-83%ee)。在的情况下获得的最高EE值(83-97%ee)的对位替换模型。在查耳酮类似物中,对于具有α-叔丁基和β-芳基基团的模型化合物,可检测到最大ee(90-92%)。使用基于葡萄糖的冠醚1,优选形成(-)-对映体,而将基于甘露糖的2用作催化剂,则(+)-对映体过量。
  • 一种吲哚类化合物的催化合成方法
    申请人:华侨大学
    公开号:CN105669517B
    公开(公告)日:2018-04-17
    本发明公开了一种吲哚类化合物的催化合成方法,包括如下步骤:(1)将邻硝基苯乙烯或其衍生物、联硼酸频那醇酯、碱和低级饱和一元醇在氮气气氛下搅拌反应;(2)将步骤(1)的反应产物冷却到室温,再加入乙酸乙酯充分混合,经过滤后,再用乙酸乙酯洗涤;(3)旋干步骤(2)所得的物料的有机相中的低级饱和一元醇,过硅胶柱,再用由石油醚和乙酸乙酯组成的洗脱剂淋洗上述硅胶柱,得到纯化产物,即所述吲哚类化合物。本发明的催化合成方法在中性条件下,利用便宜的联硼酸频那醇酯作为原料,以友好的低级饱和一元醇作为溶剂,通过简单的操作来获得吲哚类化合物,原料成本低廉易得,效率高,安全性好,具有广泛的拓展性和良好的工业应用前景。
查看更多